Australia's Next Science hits record low as HY EBITDA loss widens

Next Science

31/08/2023 03:27

** Shares of Next Science  NXS.AX  drop as much as 26.9% to
an all-time low of A$0.475
    ** Stock last down 18.5%, set for worst day since March 23,
2020, if losses hold
    ** Pharmaceuticals co reports HY underlying EBITDA loss of
$8.3 mln vs loss of $6.6 mln in pcp
    ** Co, however, reports an increase of 92% YoY in HY product
sales
    ** Adds it expects positive EBITDA and cashflow during H2 of
fiscal 2024
        ** Trading volumes 8.2 times the 30-day avg of 71,670
shares
    ** Stock down 5.1% this year, as of last close

 (Reporting by Shivangi Lahiri in Bengaluru)
 ((Shivangi.Lahiri@thomsonreuters.com;))